- Title
- Reply to Comment on: Conbercept for Treatment of Neovascular Age-Related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study
- Creators
- Kun Liu - Shanghai, ChinaXun Xu - Shanghai, ChinaPeter K Kaiser - Cleveland, OhioPhilip J Rosenfeld - Miami, FloridaJeffrey S Heier - Boston, Massachusetts
- Publication Details
- American journal of ophthalmology, Vol.215, pp.154-155
- Academic Unit
- Miller School of Medicine; UMMG Department of Ophthalmology
- Language
- English
- Resource Type
- Journal article
- PMID
- 32192739
- Record Identifier
- 991031598130902976
Journal article
Reply to Comment on: Conbercept for Treatment of Neovascular Age-Related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study
American journal of ophthalmology, Vol.215, pp.154-155
2020-03-16
PMID: 32192739
Metrics
7 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.36 Ophthalmology
- 1.36.383 Diabetic Retinopathy
- Web Of Science research areas
- Ophthalmology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites